Document Detail


Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity.
MedLine Citation:
PMID:  19268544     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent studies revealing evidence of increased serotonergic neurotransmission in schizophrenia has generated substantial interest in the role of serotonin in its pathophysiology. None of these studies, however, have queried whether dysfunctional serotonergic activity might already have been present in subjects of at-risk mental state for schizophrenia before the onset of psychotic symptoms, and whether serotonergic activity further increases during the development of schizophrenia and the chronic course. Although no valid indicator for measuring the activity level of serotonergic neurotransmission has yet been found, a series of evidence from human and animal studies suggests that a weak loudness dependence of auditory evoked potentials (LDAEP) indicates high serotonergic activity and vice versa. We examined the LDAEP (N1/P2 component) in 60 patients with at-risk mental state for schizophrenia who showed characteristic prodromal symptoms, 34 first-episode patients, 28 patients with a chronic course of schizophrenia and 57 healthy controls. Prodromal patients showed significantly weaker LDAEP in comparison to healthy volunteers, but similarly to that in first-episode and chronic patients. None of the covariates such as age, gender, medication, age of onset, or psychopathology had an influence on this finding. In a subsample of prodromal patients, LDAEP values remain the same after retesting 10 months later. These results indicate that serotonergic neurotransmission had already increased before the onset of the full-blown psychosis of schizophrenia and remains enhanced in the further course of the disease. A weak LDAEP may therefore represent a vulnerability marker rather than an expression of illness progression.
Authors:
Yehonala Gudlowski; Seza Ozgürdal; Henning Witthaus; Jürgen Gallinat; Marta Hauser; Christine Winter; Idun Uhl; Andreas Heinz; Georg Juckel
Related Documents :
21173914 - Small bowel parasitosis as cause of obscure gastrointestinal bleeding diagnosed by caps...
20569994 - Persecutory delusions and the perception of trustworthiness in unfamiliar faces in schi...
22899764 - Macular pigment parameters in patients with macular telangiectasia (mactel) and normal ...
21733944 - Reliability of the baltimore activity scale questionnaire for intermittent claudication.
18835084 - Renal transplantation does not improve erectile function in hemodialysed patients.
15789254 - Retinol binding protein status in relation to ocular surface changes in patients with c...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-03-05
Journal Detail:
Title:  Schizophrenia research     Volume:  109     ISSN:  0920-9964     ISO Abbreviation:  Schizophr. Res.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-30     Completed Date:  2009-06-03     Revised Date:  2010-09-02    
Medline Journal Info:
Nlm Unique ID:  8804207     Medline TA:  Schizophr Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  141-7     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and Psychotherapy, Charité, University Medicine of Berlin, Campus Mitte, Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acoustic Stimulation / methods*
Adolescent
Adult
Age of Onset
Chronic Disease
Disease Progression
Evoked Potentials, Auditory / physiology*
Female
Humans
Male
Middle Aged
Schizophrenia / diagnosis,  physiopathology
Serotonin / physiology*
Synaptic Transmission / physiology
Chemical
Reg. No./Substance:
50-67-9/Serotonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polymorphisms in SLC6A4, PAH, GABRB3, and MAOB and modification of psychotic disorder features.
Next Document:  Protection of Procambarus clarkii against white spot syndrome virus using inactivated WSSV.